MML Investors Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

MML Investors Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552K	Buy	16,353 +6,715	+70%	+$201K	﹤0.01%	2394
2026 Q1	$280K	Buy	9,638 +811	+9%	+$23.5K	﹤0.01%	2600
2025 Q4	$231K	Buy	+8,827	New	+$227K	﹤0.01%	2799
2022 Q1	–	Sell	-4,603	Closed	-$202K	–	2095
2021 Q4	$202K	Sell	4,603 -821	-15%	-$38.9K	﹤0.01%	1922
2021 Q3	$275K	Buy	5,424 +301	+6%	+$15.7K	﹤0.01%	1687
2021 Q2	$267K	Buy	+5,123	New	+$240K	﹤0.01%	1673

Other funds holding IDNA

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PCA

Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 23.67% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

MML Investors Services's IDNA Position: Q2 2026 in Review

MML Investors Services increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 70% in Q2 2026, buying an estimated $201K and bringing the position to 16,353 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

MML Investors Services first reported a position in IDNA in Q2 2021 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

MML Investors Services held 16,353 shares of iShares Genomics Immunology and Healthcare ETF worth $552K as of Q2 2026.
MML Investors Services bought 6,715 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $201K.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2394 holding.
MML Investors Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2021 and has held it in 6 quarters since.
33 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.